| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8414619 | European Journal of Pharmaceutics and Biopharmaceutics | 2013 | 7 Pages |
Abstract
In asthma, the airways undergo many structural and functional changes caused by environmental factors and genetic predisposition including a damaged epithelium, mucus hyper-secretion, thickening of the basement membrane, fibroblast and smooth muscle layer, angiogenesis and increased inflammation. To understand the underlying disease mechanisms, there is a need for a range of in vitro models that incorporate genetic and epigenetic features of the disease through use of asthma-derived cells.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Cornelia Blume, Donna E. Davies,
